Manchester Capital Management LLC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 178 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
Manchester Capital Management LLC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,325,000
-46.0%
65,7420.0%0.18%
-46.4%
Q2 2021$2,453,000
+45.9%
65,7420.0%0.34%
+35.2%
Q1 2021$1,681,000
+16.1%
65,7420.0%0.25%
+11.6%
Q4 2020$1,448,000
+37.6%
65,742
+12.5%
0.22%
+37.4%
Q3 2020$1,052,000
-12.1%
58,457
+24.0%
0.16%
-0.6%
Q2 2020$1,197,000
+38.2%
47,1430.0%0.16%
+18.0%
Q1 2020$866,000
-16.7%
47,1430.0%0.14%
+23.0%
Q4 2019$1,039,000
+283.4%
47,143
+150.0%
0.11%
+253.1%
Q3 2019$271,000
-8.8%
18,8570.0%0.03%
-15.8%
Q2 2019$297,000
+7.6%
18,8570.0%0.04%
+8.6%
Q1 2019$276,000
+19.5%
18,8570.0%0.04%0.0%
Q4 2018$231,000
-19.8%
18,8570.0%0.04%
-14.6%
Q3 2018$288,000
+24.7%
18,8570.0%0.04%
+17.1%
Q2 2018$231,000
+28.3%
18,8570.0%0.04%
+20.7%
Q1 2018$180,00018,8570.03%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders